Vajna, R.Z.; Géczi, A.M.; Meznerics, F.A.; Ács, N.; Hegyi, P.; Feig, E.Z.; Fehérvári, P.; Kiss-Dala, S.; Várbíró, S.; Hetthessy, J.R.;
et al. Strong Early Impact of Letrozole on Ovulation Induction Outperforms Clomiphene Citrate in Polycystic Ovary Syndrome. Pharmaceuticals 2024, 17, 971.
https://doi.org/10.3390/ph17070971
AMA Style
Vajna RZ, Géczi AM, Meznerics FA, Ács N, Hegyi P, Feig EZ, Fehérvári P, Kiss-Dala S, Várbíró S, Hetthessy JR,
et al. Strong Early Impact of Letrozole on Ovulation Induction Outperforms Clomiphene Citrate in Polycystic Ovary Syndrome. Pharmaceuticals. 2024; 17(7):971.
https://doi.org/10.3390/ph17070971
Chicago/Turabian Style
Vajna, Rita Zsuzsanna, András Mihály Géczi, Fanni Adél Meznerics, Nándor Ács, Péter Hegyi, Emma Zoé Feig, Péter Fehérvári, Szilvia Kiss-Dala, Szabolcs Várbíró, Judit Réka Hetthessy,
and et al. 2024. "Strong Early Impact of Letrozole on Ovulation Induction Outperforms Clomiphene Citrate in Polycystic Ovary Syndrome" Pharmaceuticals 17, no. 7: 971.
https://doi.org/10.3390/ph17070971
APA Style
Vajna, R. Z., Géczi, A. M., Meznerics, F. A., Ács, N., Hegyi, P., Feig, E. Z., Fehérvári, P., Kiss-Dala, S., Várbíró, S., Hetthessy, J. R., & Sára, L.
(2024). Strong Early Impact of Letrozole on Ovulation Induction Outperforms Clomiphene Citrate in Polycystic Ovary Syndrome. Pharmaceuticals, 17(7), 971.
https://doi.org/10.3390/ph17070971
